Cite
MLA Citation
David Adams et al.. “Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.” Lancet neurology, vol. 20, no. 1, 2021, pp. 49–59. http://access.bl.uk/ark:/81055/vdc_100155677830.0x00002a